Cian Healthcare Ltd.
| BSE: 542678 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE05BN01019 |
| BSE 00:00 | 01 Jul | 23.80 |
0 (0.00%) |
OPEN
23.80 |
HIGH
23.80 |
LOW
23.80 |
| NSE 05:30 | 01 Jan | Cian Healthcare Ltd |
| OPEN | 23.80 |
| PREVIOUS CLOSE | 23.80 |
| VOLUME | 2000 |
| 52-Week high | 33.80 |
| 52-Week low | 12.05 |
| P/E | |
| Mkt Cap.(Rs cr) | 60 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cian Healthcare Ltd. (CIANHEALTHCARE) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 539.20 | 5.90 | 1.11 | 15823.68 |
| Cipla | 939.75 | 2.05 | 0.22 | 13900.58 |
| Dr Reddy's Labs | 4414.30 | 24.85 | 0.57 | 13349.10 |
| Sun Pharma.Inds. | 835.25 | -0.30 | -0.04 | 12803.21 |
| Lupin | 630.90 | 3.50 | 0.56 | 11055.93 |
| Apollo Hospitals | 3857.55 | 41.05 | 1.08 | 9153.00 |
| Zydus Lifesci. | 367.40 | 6.05 | 1.67 | 7790.40 |
| Glenmark Pharma. | 383.65 | 2.35 | 0.62 | 7567.93 |
| Alkem Lab | 3047.90 | -2.50 | -0.08 | 7219.68 |
| Divi's Lab. | 3617.80 | 7.45 | 0.21 | 6798.61 |
| Torrent Pharma. | 2901.95 | 10.10 | 0.35 | 6450.83 |
| Ipca Labs. | 942.50 | 14.60 | 1.57 | 5114.11 |
| Alembic Pharma | 727.55 | 4.70 | 0.65 | 5051.44 |
| Laurus Labs | 460.45 | -2.85 | -0.62 | 4707.04 |
| Abbott India | 18703.95 | 73.15 | 0.39 | 4310.02 |
| Gland Pharma | 2578.85 | 48.85 | 1.93 | 3462.88 |
| Glaxosmi. Pharma | 1545.50 | 4.10 | 0.27 | 3217.51 |
| Granules India | 275.00 | -2.35 | -0.85 | 3134.98 |
| Sanofi India | 6492.45 | 48.80 | 0.76 | 2956.60 |
| Ajanta Pharma | 1198.00 | -21.60 | -1.77 | 2718.59 |
Quick Links for Cian Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
